European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy
Claudio Marelli
BMC endocrine disorders, 2014
View PDFchevron_right
Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR
Sharif Uddin
Clinical endocrinology, 2017
View PDFchevron_right
Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study
Sharif Uddin
European journal of endocrinology, 2017
View PDFchevron_right
Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial
Fabio Naro
The lancet. Diabetes & endocrinology, 2018
View PDFchevron_right
PREDICTIVE FACTORS OF BIOLOGICAL ADRENAL INSUFFICIENCY AFTER A LONG-TERM GLUCOCORTICOID THERAPY.
IJAR Indexing
International Journal of Advanced Research (IJAR), 2019
View PDFchevron_right
Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy
John Monson
Clinical Endocrinology, 2014
View PDFchevron_right
Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency
Carla Giordano
Default journal, 2019
View PDFchevron_right
Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency
Claudio Marelli
European journal of endocrinology / European Federation of Endocrine Societies, 2014
View PDFchevron_right
ADRENAL INSUFFICIENCY: CURRENT THERAPEUTIC REPLACEMENT STRATEGIES. IS THERE ANY EVIDENCE OF IMPROVED CLINICAL OUTCOMES WITH THE USE OF ONCE DAILY LONG ACTING HYDROCORTISONE THERAPY
Mustafa Alabousi
View PDFchevron_right
Self-perceived health status of patients with adrenal insufficiency receiving glucocorticoid replacement therapy - French data from a worldwide patient survey
Gaëlle Chenuc
Annales d'endocrinologie, 2015
View PDFchevron_right
Glucocorticoid Regimens in the Treatment of Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
Henrik Falhammar
Journal of the Endocrine Society
View PDFchevron_right
Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency
Roberta Giordano
Journal of Endocrinological Investigation
View PDFchevron_right
Pharmacokinetic Evidence for Suboptimal Treatment of Adrenal Insufficiency with Currently Available Hydrocortisone Tablets
Thierry Brue
Clinical Pharmacokinetics, 2010
View PDFchevron_right
Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency
Antoine Coquerel
PLOS ONE, 2015
View PDFchevron_right
Adrenal Insufficiency in Australia: Is it Possible that the Use of Lower Dose, Short-Acting Glucocorticoids has Increased the Risk of Adrenal Crises?
David J Torpy
Hormone and Metabolic Research, 2015
View PDFchevron_right
Predicting Recovery Of The Hypothalamic-Pituitary-Adrenal Axis After Prolonged Glucocorticoid Use
Hoe Leong Sii
Endocrine Practice, 2018
View PDFchevron_right
Improved Cortisol Exposure-Time Profile and Outcome in Patients with Adrenal Insufficiency: A Prospective Randomized Trial of a Novel Hydrocortisone Dual-Release Formulation
Pia Burman
The Journal of Clinical Endocrinology & Metabolism, 2012
View PDFchevron_right
Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis
Henrik Falhammar
Endocrine
View PDFchevron_right
Recovery of Adrenal Function in Patients with Glucocorticoids Induced Secondary Adrenal Insufficiency
JaeHoon Jung
Endocrinology and metabolism (Seoul, Korea), 2015
View PDFchevron_right
Modified release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency
Marianne Øksnes
View PDFchevron_right
Management of adrenal insufficiency
Nazim Ghouri
Journal of Diabetes and Endocrine Practice, 2021
View PDFchevron_right
Diagnosis of Adrenal Insufficiency Induced by Glucocorticoids
Cynthia Galvão Inácio
International Journal of Health Science
View PDFchevron_right
Adrenal insufficiency Caused by Chronic Corticosteroid Use, identified through Medication Therapy Management
Tsuhua Chen
The Senior Care Pharamcist, 2021
View PDFchevron_right
Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia
Wiebke Arlt
View PDFchevron_right
Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy
Elisabeth Van Rossum
Clinical Endocrinology, 2014
View PDFchevron_right
Glucocorticoid replacement
Amir Sam
BMJ, 2014
View PDFchevron_right
Bone Mineral Density in Adults With Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
Henrik Falhammar
Frontiers in Endocrinology
View PDFchevron_right
Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency
Sharif Uddin
Endocrine Connections, 2016
View PDFchevron_right
Glucocorticoid therapy and adrenal suppression
Biljana Zvezdin
Medical review, 2017
View PDFchevron_right